-
1
-
-
85013588981
-
42 CFR part 511 Medicare program; part B drug payment model; proposed rule
-
[1] Centers for Medicare & Medicaid Services. 42 CFR part 511 Medicare program; part B drug payment model; proposed rule. Fed Regist 48 (2016), 13230–13261.
-
(2016)
Fed Regist
, vol.48
, pp. 13230-13261
-
-
-
2
-
-
84940648261
-
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
-
[2] Cherny, N.I., Sullivan, R., Dafni, U., et al. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS). Ann Oncol 26 (2015), 1547–1573.
-
(2015)
Ann Oncol
, vol.26
, pp. 1547-1573
-
-
Cherny, N.I.1
Sullivan, R.2
Dafni, U.3
-
3
-
-
84939251874
-
American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options
-
[3] Schnipper, L.E., Davidson, N.E., Wollins, D.S., et al. American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol 33 (2015), 2563–2577.
-
(2015)
J Clin Oncol
, vol.33
, pp. 2563-2577
-
-
Schnipper, L.E.1
Davidson, N.E.2
Wollins, D.S.3
-
4
-
-
84976398620
-
Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received
-
[4] Schnipper, L.E., Davidson, N.E., Wollins, D.S., et al. Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received. J Clin Oncol 34 (2016), 2925–2934.
-
(2016)
J Clin Oncol
, vol.34
, pp. 2925-2934
-
-
Schnipper, L.E.1
Davidson, N.E.2
Wollins, D.S.3
-
5
-
-
85013571531
-
-
TM frequently asked questions. Available from: [Accessed August 24, ].
-
TM frequently asked questions. Available from: https://www.nccn.org/evidenceblocks/pdf/EvidenceBlocksFAQ.pdf. [Accessed August 24, 2016].
-
(2016)
-
-
-
6
-
-
85013613860
-
-
TM user guide. Available from: [Accessed August 24, ].
-
TM user guide. Available from: https://www.nccn.org/evidenceblocks/pdf/EvidenceBlocksUserGuide.pdf. [Accessed August 24, 2016].
-
(2016)
-
-
-
7
-
-
85013577204
-
Treatment Options for Relapsed or Refractory Multiple Myeloma: Effectiveness, Value, and Value-Based Price Benchmarks
-
Institute for Clinical and Economic Review Boston, MA
-
[7] Ollendorf, D., Chapman, R., Khan, S., et al. Treatment Options for Relapsed or Refractory Multiple Myeloma: Effectiveness, Value, and Value-Based Price Benchmarks. 2016, Institute for Clinical and Economic Review, Boston, MA.
-
(2016)
-
-
Ollendorf, D.1
Chapman, R.2
Khan, S.3
-
8
-
-
85013608744
-
-
NCCN clinical practice guidelines in oncology (NCCN guidelines) with NCCN Evidence Blocks. Available from: [Accessed August 25, ].
-
[8] National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines) with NCCN Evidence Blocks. Available from: https://www.nccn.org/evidenceblocks/. [Accessed August 25, 2016].
-
(2016)
-
-
-
9
-
-
84977500588
-
ICER evidence rating matrix: a user's guide
-
2016. Available from: [Accessed June 15,].
-
[9] Ollendorf D, Pearson SD. ICER evidence rating matrix: a user's guide. 2016. Available from: http://icer-review.org/wp-content/uploads/2016/01/Rating-Matrix-User-Guide-FINAL-v10-22-13.pdf. [Accessed June 15, 2016].
-
(2016)
-
-
Ollendorf, D.1
Pearson, S.D.2
-
10
-
-
85013604617
-
-
Addressing the myths about ICER and value assessment. Available from: [Accessed August 10, ].
-
[10] Institute for Clinical and Economic Review. Addressing the myths about ICER and value assessment. Available from: https://icer-review.org/myths/. [Accessed August 10, 2016].
-
(2016)
-
-
-
11
-
-
84969262222
-
Toward a patient-centered value framework in oncology
-
[11] Basch, E., Toward a patient-centered value framework in oncology. JAMA, 315, 2016, 2073.
-
(2016)
JAMA
, vol.315
, pp. 2073
-
-
Basch, E.1
-
12
-
-
84969195206
-
Utility of cancer value frameworks for patients, payers, and physicians
-
[12] Chandra, A., Shafrin, J., Dhawan, R., Utility of cancer value frameworks for patients, payers, and physicians. JAMA, 315, 2016, 2069.
-
(2016)
JAMA
, vol.315
, pp. 2069
-
-
Chandra, A.1
Shafrin, J.2
Dhawan, R.3
-
13
-
-
85013572577
-
-
Available from: [Accessed June 21, 2016]
-
[13] Dalzell, M., Considerations for designing “value calculators” for oncology therapies, 2016 Available from: http://www.ajmc.com/journals/evidence-based-oncology/2016/peer-exchange-oncology-stakeholders-summit/considerations-for-designing-value-calculators-for-oncology-therapies. [Accessed June 21, 2016].
-
(2016)
Considerations for designing “value calculators” for oncology therapies
-
-
Dalzell, M.1
-
14
-
-
85013624362
-
Lessons to learn from the NICE cancer care model
-
Available from: [Accessed August 2,].
-
[14] Dangi-Garimella S. Lessons to learn from the NICE cancer care model. Available from: http://www.ajmc.com/journals/evidence-based-oncology/2016/july-2016/lessons-to-learn-from-the-nice-cancer-care-model/P-1. [Accessed August 2, 2016].
-
(2016)
-
-
Dangi-Garimella, S.1
-
15
-
-
85013617269
-
Is there a mathematical resolution to the cost-versus-value debate?
-
[15] Feinberg, B., Lal, L., Swint, M., Is there a mathematical resolution to the cost-versus-value debate?. Am J Manag Care 21 (2015), SP542–SP544.
-
(2015)
Am J Manag Care
, vol.21
, pp. SP542-SP544
-
-
Feinberg, B.1
Lal, L.2
Swint, M.3
-
16
-
-
84975261142
-
Value: the next frontier in cancer care
-
[16] Goulart, B.H.L., Value: the next frontier in cancer care. Oncologist 21 (2016), 651–653.
-
(2016)
Oncologist
, vol.21
, pp. 651-653
-
-
Goulart, B.H.L.1
-
17
-
-
84952907922
-
Measuring the value of prescription drugs
-
[17] Neumann, P.J., Cohen, J.T., Measuring the value of prescription drugs. N Engl J Med 373 (2015), 2595–2597.
-
(2015)
N Engl J Med
, vol.373
, pp. 2595-2597
-
-
Neumann, P.J.1
Cohen, J.T.2
-
18
-
-
84952903757
-
Value-based cancer care
-
[18] Young, R.C., Value-based cancer care. N Engl J Med 373 (2015), 2593–2595.
-
(2015)
N Engl J Med
, vol.373
, pp. 2593-2595
-
-
Young, R.C.1
-
19
-
-
85013576051
-
-
Cancer facts and figures 2016. Available from: [Accessed June 21, 2016].
-
[19] American Cancer Society. Cancer facts and figures 2016. 2016. Available from: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2016/. [Accessed June 21, 2016].
-
(2016)
-
-
-
20
-
-
0028600665
-
Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology
-
[20] Cicchetti, D.V., Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 6 (1994), 284–290.
-
(1994)
Psychol Assess
, vol.6
, pp. 284-290
-
-
Cicchetti, D.V.1
-
21
-
-
78650589643
-
What is value in health care?
-
[21] Porter, M.E., What is value in health care?. N Engl J Med 363 (2010), 2477–2481.
-
(2010)
N Engl J Med
, vol.363
, pp. 2477-2481
-
-
Porter, M.E.1
-
22
-
-
84981533537
-
Value-based care in lung cancer
-
[22] Eaton, K.D., Jagels, B., Martins, R.G., Value-based care in lung cancer. Oncologist 21 (2016), 903–906.
-
(2016)
Oncologist
, vol.21
, pp. 903-906
-
-
Eaton, K.D.1
Jagels, B.2
Martins, R.G.3
-
23
-
-
84923008629
-
Developing a measure of value in health care
-
[23] Ken Lee, K.H., Matthew Austin, J., Pronovost, P.J., Developing a measure of value in health care. Value Health 19 (2016), 323–325.
-
(2016)
Value Health
, vol.19
, pp. 323-325
-
-
Ken Lee, K.H.1
Matthew Austin, J.2
Pronovost, P.J.3
-
24
-
-
85015631371
-
Value-based model: a new perspective in medical decision-making
-
[24] Riva, S., Pravettoni, G., Value-based model: a new perspective in medical decision-making. Front Public Health, 4, 2016, 118.
-
(2016)
Front Public Health
, vol.4
, pp. 118
-
-
Riva, S.1
Pravettoni, G.2
-
25
-
-
85013600727
-
-
The patient voice in value: the NHC patient-centered value model rubric. Available from: [Accessed December 9, 2016].
-
[25] National Health Council. The patient voice in value: the NHC patient-centered value model rubric. 2016. Available from: http://www.nationalhealthcouncil.org/sites/default/files/Value-Rubric.pdf. [Accessed December 9, 2016].
-
(2016)
-
-
-
26
-
-
84866712708
-
An introduction to intraclass correlation that resolves some common confusions
-
Faculty paper, Programs in Science, Technology and Values, Critical and Creative Thinking, and Public Policy, University of Massachusetts, Boston, MA. Available from: [Accessed June 15,].
-
[26] Taylor PJ. An introduction to intraclass correlation that resolves some common confusions. Faculty paper, Programs in Science, Technology and Values, Critical and Creative Thinking, and Public Policy, University of Massachusetts, Boston, MA. Available from: http://www.faculty.umb.edu/pjt/09b.pdf. [Accessed June 15, 2016].
-
(2016)
-
-
Taylor, P.J.1
|